Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.

Neurobiol Aging 2013 Jun 13;34(6):1708.e7-13. Epub 2012 Nov 13.

Department of Neurology, Oslo University Hospital, Oslo, Norway.

Genome-wide association studies have identified a number of susceptibility loci in sporadic Parkinson's disease (PD). Recent larger studies and meta-analyses have greatly expanded the list of proposed association signals. We performed a case-control replication study in a Scandinavian population, analyzing samples from 1345 unrelated PD patients and 1225 control subjects collected by collaborating centers in Norway and Sweden. Single-nucleotide polymorphisms representing 18 loci previously reported at genome-wide significance levels were genotyped, as well as 4 near-significant, suggestive, loci. We replicated 11 association signals at p < 0.05 (SNCA, STK39, MAPT, GPNMB, CCDC62/HIP1R, SYT11, GAK, STX1B, MCCC1/LAMP3, ACMSD, and FGF20). The more recently nominated susceptibility loci were well represented among our positive findings, including 3 which have not previously been validated in independent studies. Conversely, some of the more well-established loci failed to replicate. While future meta-analyses should corroborate disease associations further on the level of common markers, efforts to pinpoint functional variants and understand the biological implications of each risk locus in PD are also warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2012.10.019DOI Listing
June 2013
4 Reads

Publication Analysis

Top Keywords

susceptibility loci
8
parkinson's disease
8
genome-wide association
8
association studies
8
association signals
8
loci
6
005 snca
4
snca stk39
4
stk39 mapt
4
signals 005
4
loci replicated
4
replicated association
4
acmsd fgf20
4
gpnmb ccdc62/hip1r
4
gak stx1b
4
stx1b mccc1/lamp3
4
syt11 gak
4
ccdc62/hip1r syt11
4
mccc1/lamp3 acmsd
4
mapt gpnmb
4

Similar Publications